L.L. Siu
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Otorhinolaryngology top 10%
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 3
- Lung Cancer Research Studies 3
- Peptidase Inhibition and Analysis 3
- Co-authors
- Aaron R. Hansen (5 shared papers)Leila Khoja (1 shared paper)Tom Wei‐Wu Chen (1 shared paper)Daphne Day (1 shared paper)Sebastién J. Hotte (3 shared papers)Susan Turner (1 shared paper)L. Wang (1 shared paper)Nicole G. Chau (1 shared paper)
- Journals
- Annals of Oncology (9 papers)European Journal of Cancer (4 papers)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)Radiotherapy and Oncology (1 paper)
- Partner nations
- CanadaUnited StatesTaiwan
In The Last Decade
L.L. Siu
28 papers receiving 1.2k citations
L.L. Siu's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 727
- Otorhinolaryngology 44
- Immunology 157
- Pulmonary and Respiratory Medicine 188
- Genetics 49
Countries citing papers authored by L.L. Siu
This map shows the geographic impact of L.L. Siu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.L. Siu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.L. Siu more than expected).
Fields of papers citing papers by L.L. Siu
This network shows the impact of papers produced by L.L. Siu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.L. Siu. The network helps show where L.L. Siu may publish in the future.
Co-authors
The 25 scholars most cited alongside L.L. Siu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review Hit paper breakdown → | 2017 | 702 |
| 2 | 2011 | 117 | |
| 3 | 2019 | 92 | |
| 4 | The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma. | 1998 | 59 |
| 5 | 2011 | 43 | |
| 6 | 2014 | 34 | |
| 7 | 2021 | 26 | |
| 8 | 2019 | 14 | |
| 9 | 2007 | 13 | |
| 10 | 2015 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2018 | 7 | |
| 13 | 2003 | 7 | |
| 14 | 1997 | 6 | |
| 15 | 2004 | 6 | |
| 16 | 2006 | 6 | |
| 17 | 2016 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2021 | 4 |
About L.L. Siu
L.L. Siu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Otorhinolaryngology, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Head and Neck Cancer Studies (4 papers), Cancer Genomics and Diagnostics (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (3 papers), Lung Cancer Research Studies (3 papers), Peptidase Inhibition and Analysis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (727 citations), Otorhinolaryngology (44 citations), Immunology (157 citations), Pulmonary and Respiratory Medicine (188 citations) and Genetics (49 citations). L.L. Siu has collaborated with scholars based in Canada, United States and Taiwan. Frequent co-authors include Aaron R. Hansen, Leila Khoja, Tom Wei‐Wu Chen, Daphne Day, Sebastién J. Hotte, Susan Turner, L. Wang, Nicole G. Chau, Malcolm J. Moore and Ian F. Tannock. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Clinical Cancer Research and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.